RECRUITINGOBSERVATIONAL
Microvascular Monitoring in Circulatory Shock and Sepsis (MiMICSS)
Microvascular Monitoring in Circulatory Shock and Sepsis (MiMICSS): Prospective Observational Cohort Study
About This Trial
Investigation of the feasibility of using near-infrared spectroscopy (NIRS) to monitor microvascular function in critically ill patients.
Who May Be Eligible (Plain English)
Who May Qualify:
- Admitted to ICU
- Receiving invasive mechanical ventilation
Who Should NOT Join This Trial:
- Body Mass Index \>40
- More than 24 hours has elapsed since ICU admission
- Death is deemed to be imminent and inevitable during the next 24 hours
- Known allergy to the textile components of the device
- Significant clinical jaundice, ecchymosis
- COVID positive microbiological result
- The treating clinician believes that participation in the domain would not be in the best interests of the patient
- Consent declined from patient or authorized third party
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Admitted to ICU
* Receiving invasive mechanical ventilation
Exclusion Criteria:
* Body Mass Index \>40
* More than 24 hours has elapsed since ICU admission
* Death is deemed to be imminent and inevitable during the next 24 hours
* Known allergy to the textile components of the device
* Significant clinical jaundice, ecchymosis
* COVID positive microbiological result
* The treating clinician believes that participation in the domain would not be in the best interests of the patient
* Consent declined from patient or authorized third party
Treatments Being Tested
DEVICE
Skeletal muscle and cerebral NIRS (research device)
NIRS applied on skeletal muscle and brain on days 1, 3, and 8 of ICU admission. Monitoring applied for up to 24hrs on each day.
Locations (1)
Health Sciences Centre Winnipeg
Winnipeg, Manitoba, Canada